Pure Platelet and Leukocyte–Platelet-Rich Plasma for Regenerative Medicine in Orthopedics—Time- and Preparation-Dependent Release of Growth Factors and Effects on Synovial Fibroblasts: A Comparative Analysis

Intra-articular injections of autologous platelet concentrates are considered capable to enhance the healing of cartilage lesions, alleviate joint inflammation, and relieve other musculoskeletal pathological conditions. The aim of this study was to analyze the soluble fractions obtained from platelet-rich plasma (pure- and leukocyte-PRP) to compare time- and preparation-dependent modifications of growth factor concentrations and the supporting activity of the two preparations on synovial fibroblast growth and hyaluronic acid (HA) production in vitro. The release kinetics of FGF-2, SDF-1, VEGF, HGF, EGF, PD GF-AB/BB, IGF-1, VCAM-1, and TGF-β isoforms were followed up to 168 h after PRP activation, and their amounts were determined by multiplex-beads immunoassay. Synovial cell growth and supernatant HA production were respectively analyzed by Alamar Blue assay and ELISA. Time-dependent modifications grouped molecules in three peculiar patterns: one reaching the highest concentrations within 18 h and decreasing afterwards, another progressively increasing up to 168 h, and the last peaking at the central time points. Synovial fibroblast growth in response to L-PRP and P-PRP revealed differences over time and among added concentrations. Both preparations displayed a preserved supporting capacity of HA synthesis.

[1]  G. Ruthel,et al.  A Platelet-Rich Plasma-Derived Biologic Clears Staphylococcus aureus Biofilms While Mitigating Cartilage Degeneration and Joint Inflammation in a Clinically Relevant Large Animal Infectious Arthritis Model , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  M. Azkargorta,et al.  Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum , 2021, International Journal of Molecular Sciences.

[3]  Li-Hong Peng,et al.  Molecular Mechanisms of Chondrocyte Proliferation and Differentiation , 2021, Frontiers in Cell and Developmental Biology.

[4]  R. Takatori,et al.  The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine , 2020, International journal of molecular sciences.

[5]  Ángel García,et al.  Deciphering the secretome of leukocyte-platelet rich fibrin: towards a better understanding of its wound healing properties , 2020, Scientific Reports.

[6]  J. Eschweiler,et al.  Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis , 2020, Archives of Orthopaedic and Trauma Surgery.

[7]  E. Mariani,et al.  Platelet Concentrates in Musculoskeletal Medicine , 2020, International journal of molecular sciences.

[8]  Yong-Beom Park,et al.  Variability of the Composition of Growth Factors and Cytokines in Platelet-Rich Plasma From the Knee With Osteoarthritis. , 2019, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[9]  J H Abbott,et al.  OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. , 2019, Osteoarthritis and cartilage.

[10]  Alfred C. Gellhorn,et al.  Platelet-Rich Plasma Use in Musculoskeletal Disorders: Are the Factors Important in Standardization Well Understood? , 2019, Physical medicine and rehabilitation clinics of North America.

[11]  Nicholas M. Wragg,et al.  The use of PRP injections in the management of knee osteoarthritis , 2019, Cell and Tissue Research.

[12]  Zhongli Li,et al.  Comparative study of different anticoagulants and coagulants in the evaluation of clinical application of platelet-rich plasma (PRP) standardization , 2019, Cell and Tissue Banking.

[13]  P. Nurden,et al.  Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin. , 2019, Biomaterials.

[14]  J. Dragoo,et al.  Current Clinical Recommendations for Use of Platelet-Rich Plasma , 2018, Current Reviews in Musculoskeletal Medicine.

[15]  P. Kubes,et al.  Start a fire, kill the bug: The role of platelets in inflammation and infection , 2018, Innate immunity.

[16]  M. Quirynen,et al.  Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study , 2018, Platelets.

[17]  José F. Alfonso Sánchez,et al.  Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders , 2018, Medicine.

[18]  D. Lansdown,et al.  Platelet-Rich Plasma: Formulations, Preparations, Constituents, and Their Effects , 2017 .

[19]  M. Marcacci,et al.  Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules , 2016, BioMed research international.

[20]  M. Marcacci,et al.  Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro , 2015, BMC Microbiology.

[21]  M. Marcacci,et al.  Effect of two different preparations of platelet-rich plasma on synoviocytes , 2014, Knee Surgery, Sports Traumatology, Arthroscopy.

[22]  V. Shetty,et al.  Orthobiologics and platelet rich plasma , 2014, Indian journal of orthopaedics.

[23]  N. Maffulli,et al.  Platelet-rich plasma for managing pain and inflammation in osteoarthritis , 2013, Nature Reviews Rheumatology.

[24]  M. Marcacci,et al.  Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. , 2013, Cytotherapy.

[25]  D. Zanetta-Barbosa,et al.  Evaluation of the bone healing process utilizing platelet-rich plasma activated by thrombin and calcium chloride: a histologic study in rabbit calvaria. , 2013, The Journal of oral implantology.

[26]  P. Boileau,et al.  Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions. , 2012, Current pharmaceutical biotechnology.

[27]  Vasili Karas,et al.  Platelet-rich plasma: a milieu of bioactive factors. , 2012, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[28]  J. Dragoo,et al.  Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems , 2011, The American journal of sports medicine.

[29]  M. Egerbacher,et al.  Platelet-rich fibrin constructs elute higher concentrations of transforming growth factor-β1 and increase tendon cell proliferation over time when compared to blood clots: a comparative in vitro analysis. , 2010, Veterinary surgery : VS.

[30]  Ye Lin,et al.  A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[31]  L. Fortier,et al.  Temporal growth factor release from platelet‐rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  R. Guaschino,et al.  Not every PRP‐gel is born equal Evaluation of growth factor availability for tissues through four PRP‐gel preparations: Fibrinet®, RegenPRP‐Kit®, Plateltex® and one manual procedure , 2009, Vox sanguinis.

[33]  G. Lippi,et al.  Circadian variation within hemostasis: an underrecognized link between biology and disease? , 2009, Seminars in thrombosis and hemostasis.

[34]  D. M. Dohan Ehrenfest,et al.  Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies , 2009, Growth factors.

[35]  T. Deliberador,et al.  Bone healing in critical-size defects treated with platelet-rich plasma activated by two different methods. A histologic and histometric study in rat calvaria. , 2008, Journal of periodontal research.

[36]  G. Orive,et al.  Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. , 2008, Journal of periodontology.

[37]  E. Mariani,et al.  Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status , 2006, Biogerontology.

[38]  Helen H. Lu,et al.  Activation of platelet-rich plasma using thrombin receptor agonist peptide. , 2005, Journal of oral and maxillofacial surgery.

[39]  Helen H. Lu,et al.  Differential growth factor retention by platelet-rich plasma composites. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[40]  G. Hafner,et al.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.